Abstract:Liying Zhan, 1, &ast Zhihua Lv, 2, &ast Yunjing Zhang, 3, &ast Jingdi Chen, 4 Lu Wang, 1 Raojuan Huang, 5 Yaqi Sun, 5 Wei Wu 1 1 Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Department of Clinical Laboratory, Institute of Translational medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 3 Department of Ultrasound, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 4 Department of Orthopedics, the Airborne Military Hospital, Wuhan, Hubei, People's Republic of China; 5 First Clinical College of Wuhan University, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei Wu, Email Purpose: Application of metagenomic next-generation sequencing (mNGS) in identifying nosocomial central nervous system (CNS) infections in critical care units remains understudied. Methods: We conducted a retrospective analysis of microbiological results through both mNGS and routine examination of cerebrospinal fluid (CSF) samples from patients with nosocomial CNS infections. The aim of this study was to assess the clinical diagnostic effect of nosocomial mNGS in this population. Results: The study included 26 cases of nosocomial CNS infections in total. A total of 69.2% (18/26) of the samples tested positive for mNGS, which is substantially greater than the 7.7% (2/26; p < 0.05) detected through conventional techniques. Administration of antibiotics before culture is most likely the cause of the low CSF culture rate. Twenty-five pathogenic strains that were missed by standard testing. Three pathogens that were consistent with the mNGS results were positive by routine tests. Eight cases were negative by mNGS due to low pathogen CSF titres. Compared to traditional testing, mNGS demonstrated 100% sensitivity and 33.3% specificity in diagnosing CNS infections. The thirty-day mortality rate was 26.9% (7/26). Conclusion: Routine microbiologic testing frequently falls short of detecting all neuroinvasive pathogens. Our research suggests that mNGS offers an alternative means of detecting nosocomial CNS infections. By applying mNGS to CSF samples from patients with meningitis or encephalitis, we were able to improve the ability to diagnose nosocomial neurologic infections. Keywords: metagenomic next-generation sequencing, cerebrospinal fluid, central nervous system infections, diagnosis Central nervous system (CNS) infections affecting the brain and spinal cord are primarily caused not only by bacteria and viruses but also by fungi and parasites. CNS infections are severe and life-altering conditions, and they are the most frequent cause of hospitalizations in many developing countries, making them a significant public concern. 1 Globally, CNS infectious disease has a high mortality rate. 2 It is difficult to diagnose CNS infections. Due to limited diagnostic capacity and difficulties involved in performing exploratory lumbar punctures, there is a dearth of information regarding aetiology. PCR and culture are useful techniques for detecting pathogenic bacteria, but uncommon pathogenic bacteria involving CNS infections remain difficult to identify by PCR and culture. 3 First, antibiotic treatment reduces the detection rate of CSF culture, which is the gold standard for diagnosing bacterial meningitis, and the majority of patients receive antibiotic treatment prior to lumbar puncture. Moreover, different media and cultivation conditions-some of which are intricate and time consuming-are necessary for microbial culture. The presence of Bartonella , for instance, which grows in culture for roughly two weeks, 4 reduces diagnostic efficiency. Furthermore, accurate primers are needed for PCR amplification procedures, and if the primers do not match the target nucleic acid sequence, the results may be erroneous. Thus, the rate of positive detection for PCR amplification techniques is low. 5 Overall, conventional detection techniques have several limitations, 6 and it is difficult to culture organisms from patients with CNS infections, 7 almost half of CNS infection patients cannot receive an aetiological diagnosis. 8 CNS infection diagnosis is a very challenging task. Nevertheless, precise identification of CNS infections (mixed infections) plays a vital role in clinical therapy. Recently, next-generation sequencing (NGS) has opened a window into the infectious diseases. Pathogen-targeted NGS (p -Abstract Truncated-

16S Ribosomal Assay for Early Diagnosis of Gonococcal Meningitis with Negative CSF Culture: A Case Report.

Rapid Diagnosis and Discrimination of Bacterial Meningitis in Children Using Gram Probe Real-Time Polymerase Chain Reaction

Case Report: Streptococcus Suis Meningitis Diagnosed in a HIV-Infected Patient with Cryptococcal Meningitis Using Next-Generation Sequencing

Rapid Diagnosis of Purulent Meningitis in Neonates by 16srrna Microarrays

Rapid Diagnosis of Bacterial Meningitis in Children with Fluorescence Quantitative Polymerase Chain Reaction Amplification in the Bacterial 16S Rrna Gene

16S rDNA PCR-DGGE and sequencing in the diagnosis of neonatal late-onset septicemia

A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS

Employment of Broad Range 16S Rdna PCR and Sequencing in the Detection of Aetiological Agents of Meningitis.

A Case of Gonococcal Meningitis Caused by Neisseria Gonorrhoeae MLST ST7363 in a Healthy Young Adult

Case Report: A Candida Meningitis in an Immunocompetent Patient Detected Through the Next-Generation Sequencing

mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study

Use of Metagenomic Next-Generation Sequencing to Identify Pathogens Involved in Central Nervous System Infections

Next-Generation Sequencing Could be a Promising Diagnostic Approach for Pathogen Detection: Pathogenic Analysis of Pediatric Bacterial Meningitis by Next-Generation Sequencing Technology Directly from Cerebrospinal Fluid Specimens

Metagenomic Next-Generation Sequencing Direct Diagnosis of Mixed Bacterial Meningitis in a Child: A Case Report

Evaluation of metagenomic and pathogen-targeted next-generation sequencing for diagnosis of meningitis and encephalitis in adults: A multicenter prospective observational cohort study in China

Pathogen Identification in Culture-Negative Cerebrospinal Fluid Specimens of Patients with Purulent Meningitis Using Next-Generation Sequencing Technology.

Diagnostic Performance of Noncultural Methods for Central Nervous System Aspergillosis

Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a retrospective study of 90 patients

Performance of Metagenomic Next-Generation Sequencing for the Diagnosis of Cryptococcal Meningitis in HIV-Negative Patients

PCR-positive meningococcal CSF infection without pleocytosis but high IL-6 and IL-8

Irreversible neurological manifestations in undiagnosed disseminated gonococcal infection